Proxim Diagnostics Achieves Final Development Milestone for Immunodiagnostic Platform
Proxim Diagnostics Corp. has announced the completion of a final development milestone for its handheld, point-of-care immunodiagnostic platform, the Profile. This includes the successful development of the handheld reader, disposable cartridge, and initial manufacturing capacity, moving the platform into production readiness for future clinical and strategic partnerships.
SANTA CLARA, Calif.–(BUSINESS WIRE)–Proxim Diagnostics Corp., an innovative company developing a handheld, point-of-care immunodiagnostic platform, announced that it has achieved a final development milestone for its Profile platform, including completion of the handheld reader, disposable cartridge, and initial manufacturing capacity. This milestone marks the transition of Proxim’s platform from its product development phase into production readiness for future clinical and strategic partner
